Germ cell tumors (GCT) are a rare form of childhood cancer that originate from the primordial germ cell. Recent genome-wide association studies (GWAS) have identified susceptibility alleles for adult testicular GCT (TGCT). We test whether these SNPs are associated with GCT in pediatric and adolescent populations. This case-parent triad study includes individuals with GCT diagnosed between ages 0 and 19. We evaluated 26 SNPs from GWAS of adult TGCT and estimated main effects for pediatric GCT within complete trios (N 5 366) using the transmission disequilibrium test. We used Estimation of Maternal, Imprinting and interaction effects using Multinomial modelling to evaluate maternal effects in non-Hispanic white trios and dyads (N 5 244). We accounted for multiple comparisons using a Bonferroni correction. A variant in SPRY4 (rs4624820) was associated with reduced risk of nal parent-of-origin effect was observed for rs7221274 (P 5 0.00007), near TEX14, RAD51C, and PPM1E. We observed associations between SNPs in SPRY4, BAK1, and GAB2 and GCTs. This analysis suggests there may be common genetic risk factors for GCT in all age groups.
of origin, the primordial germ cell (PGC), 2, 3 these tumors are heterogeneous and include teratomas and yolk sac tumors (YST) of infants and young children (Type I tumors) and germinomas and nonseminomas of adolescents and young adults (Type II tumors). 4 In addition, tumors can present as a mixture of these types. Their etiology remains poorly understood and evidence suggests that GCTs, including those in adults, are initiated in utero. [5] [6] [7] Thus, alterations in normal embryonic development are likely to be especially relevant to GCT etiology.
Studies of adult testicular GCT (TGCT) have shown strong heritability of these tumors, [8] [9] [10] [11] [12] suggesting a role for genetic factors in their etiology. 13 There are few studies on family history of cancer in pediatric GCTs, and none with a sufficient sample size to specifically evaluate family history of GCT. [14] [15] [16] Although a major susceptibility gene for adult TGCT has not been identified, genome-wide association studies (GWAS) have found susceptibility loci for TGCT near KITLG, SPRY4, BAK1 17, 18 ; DMRT1, TERT, ATF7IP 19, 20 ; SLC25A44, UCK2, DAZL, CENPE, PITX1, PRDM14, MFSD1, TEX14, RAD51C, PPM1E, MCM3AP 21, 22 ; HPGDS, MAD1L1, RFWD3, 23,24 HNF1B, 25 and GSPT1, ZFPM1, GAB2.
26
Several of these genes are involved in survival (KITLG 27 ) or early differentiation of PGCs (DAZL 28 ), regulation of transcription (DMRT1 29 and PRDM14 30, 31 ), and spermatogenesis (TEX14, RAD51C, PPM1E [32] [33] [34] [35] ) and therefore are plausibly involved in TGCT, and potentially pediatric GCT, etiology.
Several susceptibility genes for GCT have been identified among male mice in the 129/Sv mouse model of testicular teratoma, 4 including Dnd1 36 and Dmrt1. 29 The tumors that arise in 129/Sv mice most closely resemble GCTs that occur in children, 4 providing evidence that genetic susceptibility may also be important in pediatric GCTs. Additionally, adult and pediatric GCTs share the primordial germ cell as their common cell of origin and tumors of differing types, including both testicular and ovarian tumors, can be classified together based on their chromosomal complement and developmental potential, as proposed previously. 4 Due to these shared characteristics, we hypothesized that genetic risk factors of adult TGCT may impact pediatric GCTs of all types. Furthermore, recent evidence indicates that all malignant GCTs over-express two microRNA clusters, regardless of patient age, histology, or tumor location, providing additional evidence of common biological characteristics across all types of GCTs. 37 In an independent study, we previously reported associations between SNPs in three of these genes (KITLG, SPRY4, and BAK1) and pediatric GCT, 38 providing further support for a shared genetic etiology. Here, we analyzed 26
SNPs at 21 independent loci identified in GWAS of adult TGCT in a case-parent triad study of pediatric and adolescent GCT to determine whether variation at these loci correlates with risk in the younger age group.
| MATERIALS A ND METHODS

| Study participants
Children and adolescents diagnosed with GCT were identified through the Children's Oncology Group Childhood Cancer Research Network (CCRN) 39 and invited to participate in this case-parent triad study. Saliva DNA was collected from the children with GCT and their biological parents for use in genetic analyses, and lifestyle and environmental risk factors were assessed using mailed questionnaires.
All participants received a saliva collection kit (Oragene, Ottowa, Ontario, Canada) with instructions and mailer with return postage.
Parents and children 5 years received a standard Oragene saliva DNA kit. Children < age 5 years received the Oragene kit for assisted DNA collection, which uses absorbent sponges. Participants were re-contacted within six months of donation for additional samples if DNA yield was insufficient. This analysis is based on an interim dataset including participants recruited to the study through December 13, 2013.
All study procedures were approved by the University of Minnesota Institutional Review Board.
| A priori variant selection
A literature review of search terms 'germ cell tumor', 'testicular germ cell', 'genetic susceptibility', and 'GWAS' identified 10 articles. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] These manuscripts together identified 31 variants in 25 genes that reached study-wide significance and were therefore considered in the current study. Only the following four variants were not tagged well (r 2 > 0.80) by any variant on the genotyped array and hence were not assessed in the current study: rs11705932 in TFDP2, rs12699477 in
upstream of PRDM14, and rs2195987 in RPSAP58. The final variant excluded from the current study (rs6897876) is in high LD (r 2 > 0.94) with rs4624820, and both are in the same region of SPRY4. As rs6897876 was tagged by rs4624820, we elected to include only the latter variant in this analysis.
| DNA extraction
Saliva samples were stored at room temperature and batched for DNA extraction. We performed automated DNA isolation using Autopure LS system (Qiagen, Venlo, Netherlands) and Puregene chemistry (Gentra Systems, Minneapolis, MN) according to the manufacturer's protocols.
DNA yield was quantified using 1:10 diluted DNA performed in triplicate by quantitative real-time PCR using absolute quantification on an ABI 7900 Prism real-time instrument and extracted DNA was aliquoted and stored at 2208C until genotyping. 3.65%). Variants were removed if: (1) the minor allele frequency of the founders (parents) was less than 0.01 in the data set (n 5 242,287;
44.65%); (2) there were differential rates of missing genotypes in the probands versus the parents (P < 0.0001; n 5 9) or males versus females (P < 0.0001; n 5 1121, 0.21%), (3) allele frequencies differed between males and females (P < 0.0001; n 5 143; 0.03%), (4) significant deviation from Hardy-Weinberg equilibrium was observed in the founders (P < 0.00001; n 5 8123; 1.5%), or (5) significant deviation from expected when imputing the variant from nearby markers using PLINK's -mishap test (P < 0.0001; n 5 8133; 1.5%). Many markers failed multiple tests. The final data set consisted of 275,996 variants that passed all quality control measures for use in defining ancestry.
| Statistical methods and analysis
The transmission disequilibrium test (TDT) as implemented in PLINK was the primary method for estimating main effects, which by design controls for population stratification. Subgroup analyses were conducted by age, sex, histology, and tumor location. Maternal effects and parent of origin effects were tested using a log-linear model in EMIM (Estimation of Maternal, Imprinting and interaction effects using Multinomial modelling). This method requires a homogeneous ancestral population and was therefore restricted to non-Hispanic whites. This status was determined by performing a principal components analysis (PCA) as implemented in EIGENSOFT 41 that included HapMap samples (CEPH Caucasian, Yoruba, Han Chinese, Japanese) as anchors. We used a Bonferroni correction to establish a threshold for statistical significance (P < 0.00192 for 26 tests). The allele frequency of all markers passing quality control was compared between CEU HapMap samples and study samples that self-described as white. Those markers with significantly different frequencies (P < 0.05; n 5 9,123) were excluded prior to running the PCA. The first two principal components from the analysis were plotted and those samples clustering tightly with the CEU samples were defined as white non-Hispanic in subsequent EMIM analyses.
| R E S U L T S
DNA was available for 366 complete trios. Among the children with GCTs, 184 (50%) were male and 182 were female, and 59% were age 11-19 years at diagnosis (Table 1) . Most participants were white, nonHispanic (56%) or Hispanic (35%). Testicular and ovarian tumors represented 25% and 27% of our sample, respectively, while 21% were intracranial and 28% were extragonadal. The most frequent tumor histologies were mixed/other (32%) and germinomas (29%). Twenty two percent of tumors were classified as teratomas and 17% were yolk sac tumors (Table 1) .
Among all samples, three loci reached the multiple testing-corrected statistical significance threshold (P < 0.00192 for 26 tests; Table 3 ). We observed a maternal parent-of-origin association for the BAK1 variant rs210138 (P 5 0.0016) and a paternal parentof-origin association for the variant near TEX14, RAD51C, and PPM1E (rs7221274; P 5 0.00019). Using the EMIM software, it is also possible to remove the child's main effect from the parent-of-origin effect.
When that is done, the parent-of-origin effect for the BAK1 variant rs210138 went away (maternal imprinting minus child P 5 0.26), whereas the signal for rs7221274 became even stronger (paternal imprinting minus child P 5 0.00007).
| DISCUSSION
We observed statistically significant associations between SNPs in SPRY4, BAK1, and GAB2 and pediatric and adolescent GCTs, with a particularly strong association between the variant in BAK1 and testicular tumors. We also observed maternal associations for SNPs near KITLG and the locus containing TEX14, RAD51C, and PPM1E. We did not observe either direct or maternal effects for the other loci identified by previous studies of adult TGCT; however, there were eight other loci for which P-values met the unadjusted but not the adjusted significance threshold. We investigated a relatively small number of SNPs with strong evidence to justify possible associations, and the multiple comparisons correction greatly reduced study power with the limited sample size. Without subsequent validation studies it is not possible to distinguish whether these additional eight loci have real or random associations with pediatric TGCT risk, and we still consider them plausible candidates for future investigation.
The SNPs identified in the GWAS of adult TGCT were notable both for their large effect sizes relative to GWAS of other adult cancers and because many were found in or near genes that are important in germ cell biology. Only one previous study has examined the association between adult TGCT GWAS loci and pediatric GCT. 38 That study, which used an independent sample set with no overlap in the current study, evaluated four SNPs, three of which were tested in the current analysis (rs4474514, rs210138, and rs755383). In that study the BAK1 SNP (rs210138) was also associated with increased risk of GCT overall 
50.84).
In this larger study of pediatric GCT, we did not replicate findings for the KITLG variant, although we did observe maternal effects for this SNP. This discrepancy in findings may be due to differences in sample composition, as the previous study consisted of 71% female cases. However, when we limited the current study to female cases, we observed a null association between the KITLG variant and GCT. Alternatively, the association reported may have been a chance finding which was not observed within the larger present dataset. We also observed similar results for the BAK1 SNP and a variant in SPRY4 in high linkage disequilibrium with the previously evaluated variant. When we combined estimates Mouse studies show that germ cells originate on the yolk sac then migrate through the dorsal mesentery of the hindgut 42 before populating the genital ridges. 43 In normal fetal development, PGCs that remain in the midline go through a rapid process of cell death through intrinsic apoptosis pathways. 27 Thus it is plausible that genes involved in the survival, differentiation, and apoptosis of PCGs are relevant to germ cell tumor development. The rs210138 variant is located within an intron of BAK1 (BCL2-antagnoist/killer 1), which encodes a protein that induces apoptosis by binding to and antagonizing the apoptosis repressor activity of BCL2 and other anti-apoptotic proteins. 44 The KIT/KITLG pathway is involved in the survival of primordial germ cells during migration to the genital ridge. 27 The KITLG pathway also represses expression of BAK1 in testicular germ cells, and interaction of BAK1 with anti-apoptotic proteins is implicated in the germ cell apoptosis that occurs in response to blockage of this pathway. 44 The mouse orthologue of KITLG (Kitl, encoded at the steel locus) is also a modifier of TCGT susceptibility in the 129/Sv mouse. 45 SPRY4 (Sprouty RTK signaling antagonist 4) is also associated with the KITLG pathway. 46 Additionally, it inhibits the mitogen-activated protein kinase (MAPK) pathway. 47 Ovarian germ cell tumors were recently found to harbor somatic mutations in MAPK1.
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GAB2 (GRB2-associated binding protein 2) encodes a docking protein involved in signal transduction from tyrosine kinases. Its role in carcinogenesis is highly plausible given its involvement in cell proliferation and cell transformation. Indeed, it has previously been shown to function as a proto-oncogene within melanoma, hepatocellular carcinoma, and breast, colorectal, and ovarian cancers. [49] [50] [51] Although the association with rs948662 that exceeded the multiple-testing correction threshold was for overall GCT risk, we observed increased point estimates of similar magnitude and nominal associations for this variant and ovarian and intracranial tumors and germinomas.
We observed a maternal effect for rs4474514 near KITLG.In 129/ Sv mice, the ortholog of KITLG is a modifier of TGCT risk. 45 Although the functional mechanism of KITLG in TGCT is not known, studies of knockout mice suggest these genes may prevent germ cell apoptosis. 27 While the role of the maternal genome in modifying risk of pediatric GCT is unclear, a recent study in zebrafish showed that maternal genes are essential in the regulation of PGC properties in the offspring. 52 Furthermore, a study of maternal effects in testicular cancer showed increased risk in offspring associated with interaction between maternal variants in KITLG and SHBG. 53 Additional support for a role of maternal genetic factors on offspring GCT risk includes evidence that variations in the maternal cytochrome p450 gene impact offspring risk of TGCT 54 and the observation of a parent-of-origin effect for SPRY4. 55 In the present study, maternal origin of the variant allele conferred an increased risk of TGCT in offspring.
A maternal parent-of-origin effect of the BAK1 variant rs210138
was detected, but became non-significant after removing the influence of the child's main effect. In contrast a paternal parent-of-origin effect of the rs7221274 variant near TEX14, RAD51C, and PPM1E
(P 5 0.0002) became even stronger after removing the main effect of the child (P 5 0.00007). This same variant also had evidence of a | 555 mothers', it likely that the parental group with the significantly different allele frequency was the fathers and not the mothers. The most likely impact of a parent-of-origin effect is imprinting, an epigenetic event in which gene expression is modified based on the transmitting parent. 56 Our observation of a parent-of-origin effect may indicate that gene expression of this locus is altered in pediatric and adolescent GCT.
Molecular evidence for imprinting is necessary to confirm this potential.
Pediatric and adolescent GCTs are a heterogeneous group of tumors. Recent studies have shown that the differing histological subtypes not only have separate DNA methylation profiles 57, 58 but also exhibit differences in microRNA expression 59 and distinct transcriptome profiles. 60 Furthermore, adult TGCTs arise from PGCs at a different developmental stage than those that occur in children.
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Therefore it is not surprising that our results differed by age group, histology, and tumor location and that we did not observe associations for all SNPs. However, recent evidence suggests that there may be cases of TGCT diagnosed in adulthood that, other than age of onset, meet the criteria of a pediatric GCT. 62 Thus, there may be shared etiology between pediatric and adult cases among a subgroup of patients.
This study is the first to use germline DNA in an investigation of genetic risk factors for pediatric GCT. It is also the first comprehensive examination of the association of TGCT-associated variants with risk of pediatric GCT. Strengths of this study include the strong a priori hypothesis that adult TGCT and pediatric GCT may share common genetic causes, including the biological plausibility of variants identified by adult TGCT GWAS. This study had a large sample size overall, although our power was limited in subtype analyses.
We found evidence that GCTs in all age groups may share some genetic risk factors. In addition, ours is the first study to report maternal effects in pediatric GCT for genes associated with adult TGCT.
Additional studies are needed to confirm these results. Fine mapping and functional studies are also needed to elucidate the mechanisms driving these associations in GCTs in all age groups.
